Ex-Alameda Research CEO Caroline Ellison Sentenced to Two Years in Prison for Her Role in FTX Fraud
Caroline Ellison was sentenced Tuesday afternoon.
Binary trading platforms with better performance and payouts
top news
Caroline Ellison was sentenced Tuesday afternoon.
FTX founder Sam Bankman-Fried filed to appeal his conviction and sentence for fraud and conspiracy charges on Thursday, hours before his deadline to do so.
A federal judge sentenced FTX founder Sam Bankman-Fried to a quarter-century in prison Thursday.
Sam Bankman-Fried’s lawyers have pushed back against the U.S. government’s sentencing memo which makes the case for why it thinks the former FTX CEO should be handed a sentence in the range of 40-50 years, a court filing on Wednesday shows.
Sam Bankman-Fried’s defense team pushed back against what it called the “disturbing” sentencing memorandum filed by the Department of Justice last week in a new letter, saying the DOJ was making the FTX founder out to be someone he was not.
Spot bitcoin ETFs are launching in the U.S. on Thursday. Here’s what the issuers and exchanges behind these products have to say.
U.S. Securities and Exchange Commission (SEC) Chair Gary Gensler conceded that the regulator’s loss in court over rejecting Grayscale’s application for a spot bitcoin exchange-traded fund (ETF) left it little recourse but to approve about a dozen such proposals Wednesday.
The entire crypto world and much of the U.S. financial sector is anxiously awaiting word from the U.S. Securities and Exchange Commission (SEC) on whether it will approve a spot bitcoin exchange-traded fund (ETF). SEC Chair Gary Gensler has chosen this moment to issue a broad warning about the hazards to investors of getting into digital assets.
Prometheum Inc., with the latest regulatory notch on its belt, is about to finally test whether a viable crypto platform can operate entirely within U.S. Securities and Exchange Commission (SEC) regulations.
Bankman-Fried’s defense team asked for a four to six week extension for his sentencing scheduled in late March, citing a possible second trial that may begin earlier in the month.